Macchia, Gabriella
 Distribuzione geografica
Continente #
EU - Europa 6.083
NA - Nord America 5.417
AS - Asia 1.094
AF - Africa 70
SA - Sud America 17
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 9
Totale 12.703
Nazione #
US - Stati Uniti d'America 5.364
DE - Germania 2.603
SE - Svezia 1.174
CN - Cina 703
UA - Ucraina 543
IT - Italia 520
IE - Irlanda 305
FR - Francia 250
GB - Regno Unito 206
FI - Finlandia 158
PL - Polonia 145
IN - India 141
TR - Turchia 99
CI - Costa d'Avorio 53
CA - Canada 50
BE - Belgio 41
JP - Giappone 32
IR - Iran 30
RU - Federazione Russa 25
NL - Olanda 24
CZ - Repubblica Ceca 23
HK - Hong Kong 22
VN - Vietnam 15
SG - Singapore 13
ES - Italia 11
EU - Europa 11
RO - Romania 9
AU - Australia 8
CH - Svizzera 8
EG - Egitto 7
AE - Emirati Arabi Uniti 5
AT - Austria 5
CL - Cile 5
GR - Grecia 5
BH - Bahrain 4
BR - Brasile 4
HU - Ungheria 4
MT - Malta 4
PH - Filippine 4
PK - Pakistan 4
PT - Portogallo 4
RS - Serbia 4
AR - Argentina 3
DZ - Algeria 3
PE - Perù 3
SA - Arabia Saudita 3
BD - Bangladesh 2
DK - Danimarca 2
EC - Ecuador 2
HR - Croazia 2
IL - Israele 2
IQ - Iraq 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MA - Marocco 2
MK - Macedonia 2
MY - Malesia 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
BZ - Belize 1
CM - Camerun 1
EE - Estonia 1
ET - Etiopia 1
ID - Indonesia 1
JO - Giordania 1
KE - Kenya 1
KW - Kuwait 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
UG - Uganda 1
Totale 12.703
Città #
Chandler 1.363
Ashburn 434
Jacksonville 321
Dublin 302
San Mateo 260
Nanjing 199
Wilmington 181
Dearborn 165
Warsaw 144
Nürnberg 140
New York 135
Boston 124
Bremen 123
Milan 122
Woodbridge 115
Marseille 112
Ann Arbor 106
Beijing 94
Izmir 88
Lawrence 85
Cattolica 82
Houston 79
Princeton 79
Fairfield 76
Nanchang 76
Rome 61
Redwood City 56
Helsinki 55
Seattle 55
Abidjan 53
Brussels 41
Leawood 40
University Park 36
Zhengzhou 35
Shenyang 33
Hebei 32
Phoenixville 32
Kunming 31
Augusta 29
Fremont 29
Los Angeles 28
Tianjin 28
Changsha 26
Jiaxing 26
Lancaster 26
Munich 26
Cambridge 25
Falls Church 25
Mountain View 25
Boardman 24
Norwalk 23
Pune 22
Detroit 21
North York 21
Auburn Hills 20
Toronto 20
Redmond 18
Hangzhou 17
Chicago 14
Hanoi 14
Lanzhou 13
Monmouth Junction 13
Shanghai 13
Washington 13
Guangzhou 12
Amsterdam 11
Andover 10
Ardabil 10
Hong Kong 10
Edinburgh 9
San Francisco 9
Hefei 8
Sacramento 8
Berlin 7
Central District 7
Indiana 7
Jinan 7
London 7
Ningbo 7
Phoenix 7
Tokyo 7
Mumbai 6
Sergii 6
Simi Valley 6
Bari 5
Bologna 5
Brno 5
Chengdu 5
Costa Mesa 5
Kish 5
Landshut 5
Lappeenranta 5
Singapore 5
Wuhan 5
Zanjan 5
Belgrade 4
Cairo 4
Cedar Knolls 4
Changchun 4
Dresden 4
Totale 6.360
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 789
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 249
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 157
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 156
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 141
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 138
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 135
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 132
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 131
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 131
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 130
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 127
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 125
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 124
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 122
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 122
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 121
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 121
Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report 120
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 120
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 119
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 118
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 118
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 118
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 118
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 118
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 118
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 116
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 115
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 113
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 110
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 108
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 106
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 105
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 105
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 104
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 104
In Vivo Portal Dosimetry by an Ionization Chamber 103
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 103
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 103
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 103
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 102
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 102
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 101
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 101
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 98
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 97
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 97
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 96
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 94
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 94
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 92
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 92
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 92
An in-vivo dosimetry procedure for Elekta step and shoot IMRT 90
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 89
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 89
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 89
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 89
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 87
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 87
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 86
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 85
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: Impact on outcome and treatment-related complications. 84
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 84
Real time transit dosimetry for the breath-hold radiotherapy technique experience 83
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 82
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 82
Underuse of brachytherapy for the treatment of dysphagia owing to esophageal cancer. An Italian survey 80
Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery. 79
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 79
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 79
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 78
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 78
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 76
Synchronous male carcinoma of the breast, exocrine pancreas, and prostate 76
Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study 76
Successful Treatment of a Young Patient with Locally Advanced Clear Cell Adenocarcinoma of the Uterine Cervix Undergoing Chemoradiation Followed by Radical Surgery 75
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 74
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 74
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 73
Optimal beam margins in linac-based VMAT stereotactic ablative body radiotherapy: A Pareto front analysis for liver metastases 72
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 72
Clinical outcome of recurrent locally advanced cervical cancer (LACC) submitted to primary multimodality therapies 70
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 70
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 69
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 68
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 67
Completion surgery after concomitant chemoradiation in locally advanced cervical cancer: a comprehensive analysis of pattern of postoperative complications 66
Linac-based extracranial radiosurgery with Elekta volumetric modulated arc therapy and an anatomy-based treatment planning system: Feasibility and initial experience 66
Videoconferencing to enhance the integration between clinical medicine and teaching: a feasibility study 65
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 64
Individually optimized stereotactic radiotherapy for pancreatic head tumors: A planning feasibility study 64
Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups 64
A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma. 63
Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study 63
Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment 61
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 59
Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD) 58
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 57
Totale 10.415
Categoria #
all - tutte 44.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.641


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019242 0 0 0 0 0 0 0 0 0 0 155 87
2019/20202.040 299 123 109 81 156 189 243 122 196 159 228 135
2020/20211.214 64 141 24 136 161 48 128 31 129 98 197 57
2021/20221.580 153 107 15 107 111 57 23 216 62 111 308 310
2022/20233.828 521 539 262 610 263 423 223 292 419 79 148 49
2023/20241.326 66 484 75 129 52 215 101 131 20 52 1 0
Totale 13.356